HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 18375676, compound → 2-[(S)-1-Phenylethylamino]-4-[5-(purin-4-yl)benzimidazol-1-yl]pyrimidine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | HCID 18375676 | HCID 18375676 | — |
| Reactant | HCID 69963704 | HCID 69963704 | — |
| Product | 2-[(S)-1-Phenylethylamino]-4-[5-(purin-4-yl)benzimidazol-1-yl]pyrimidine | HCID 69964391 | — |
Reaction Steps
The title compound was prepared according to the procedure described in EXAMPLE 424, starting from 2-[(S)-1-Phenylethylamino]-4-[5-trimethylstannylbenzimidazol-1-yl]pyrimidine and 4-chloropurine. Mass spectrum (ESI) 443.4 (M+).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06498165B1 |
| Source dataset | uspto-grants-2002_12 |
| ORD ID | ord-f775a191502648fdba30b7c4f04f769f |
| Source note | uspto-grants-2002_12 |